We are live on
!
Find out more
VYNT
Vyant Bio, Inc. Common Stock
VYNT
VYNT
Delisted
VYNT was delisted on the 12th of May, 2023.
26 hedge funds and large institutions have $4.26M invested in Vyant Bio, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
16% more capital invested
Capital invested by funds: $3.66M → $4.26M (+$592K)
13% more funds holding
Funds holding: 23 → 26 (+3)
Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$286K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$279K |
| 3 |
Renaissance Technologies
New York
|
+$86.7K |
| 4 |
VF
Virtu Financial
New York
|
+$44.8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$32.7K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
26
Credit Suisse
Zurich,
Switzerland
| – | -$9K | -67 | Closed |
|
27
SEI Investments
Oaks,
Pennsylvania
| – | -$4K | -33 | Closed |
|